Autism Consortium

The Autism Consortium has selected a microarray technology developed by Affymetrix Inc., of Santa Clara, Calif., for a comprehensive study on genes associated with autism. The technology is a result of an ongoing collaboration between the company and scientists at the Broad Institute of MIT and Harvard and will enable researchers to analyze thousands of gene samples from autistic subjects.





LATEST NEWS

• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024
• CLEO Heads to the East Coast
  Apr 29, 2024
• Laser-Based Gas Analyzer Developed to Detect Air Pollution
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024
• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024